Actionnariat et activité des initiés pour Matinas BioPharma Holdings, Inc. (MTNB): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.17 |
| Capitalisation | $1M |
| Bourse | AMEX |
| Pays | US |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $4.1M | $7.3M | $12.4M | $22.2M | $12.4M | $21.0M | $6.9M | $4.8M | $7.3M | $4.0M |
| Placements à Court Terme | 0 | 0 | 0 | $5.6M | $46.2M | $28.6M | $21.9M | $9.0M | 0 | 0 |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $4.6M | $8.0M | $13.1M | $29.9M | $61.6M | $51.0M | $34.5M | $15.5M | $8.0M | $4.1M |
| Immobilisations Corporelles | $356000 | $1.6M | $2.0M | $5.6M | $4.9M | $5.8M | $5.7M | $5.0M | $2.2M | $673000 |
| Goodwill | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | $1.3M | 0 | 0 |
| Actifs Incorporels | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $3.0M | $2.3M | $2.3M |
| Actifs Totaux | $9.8M | $14.4M | $19.9M | $40.2M | $71.0M | $61.3M | $78.9M | $25.1M | $12.6M | $7.2M |
| Dettes Fournisseurs | $475602 | $582867 | $295652 | $679310 | $349941 | $937000 | $618000 | $514000 | $95000 | $315000 |
| Dette à Court Terme | $118046 | $170236 | $199842 | 0 | 0 | 0 | $569000 | 0 | 0 | $696000 |
| Passifs Courants | $1.4M | $2.2M | $2.8M | $3.1M | $3.6M | $4.3M | $4.3M | $2.6M | $2.7M | $1.5M |
| Dette à Long Terme | 0 | 0 | 0 | $3.75B | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $2.7M | $3.7M | $3.8M | $7.2M | $7.2M | $8.8M | $42.2M | $5.9M | $5.1M | $2.4M |
| Réserves | -$35.2M | -$51.3M | -$65.9M | -$84.4M | -$107.5M | -$131.6M | -$152.6M | -$175.6M | -$199.8M | -$210.8M |
| Capitaux Propres | $7.1M | $10.7M | $16.1M | $33.1M | $63.7M | $52.5M | $36.6M | $19.2M | $7.6M | $4.8M |
| Dette Totale | $144428 | $264894 | $390743 | $4.2M | $3.8M | $4.7M | $4.1M | $3.6M | $2.9M | $1.4M |
| Dette Nette | -$4.0M | -$7.0M | -$12.1M | -$23.5M | -$54.9M | -$44.9M | -$24.7M | -$10.2M | -$4.4M | -$2.6M |
| Fonds de Roulement | $3.1M | $5.7M | $10.2M | $26.8M | $58.0M | $46.6M | $30.2M | $12.9M | $5.4M | $2.6M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 0.85 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -42.88 |
Rentabilité
| Rentabilité des capitaux propres | -181.45% |
| Rentabilité du capital investi | -323.22% |
| Rentabilité des actifs | -214.21% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ACXP · ADIL · ADXN · BCLI · CDIO · HCWB · IBO
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de MTNB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions